{"id":890141,"date":"2025-09-29T09:30:25","date_gmt":"2025-09-29T13:30:25","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\/"},"modified":"2025-09-29T09:30:25","modified_gmt":"2025-09-29T13:30:25","slug":"electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\/","title":{"rendered":"electroCore Announces Reimbursement Approval for gammaCore\u2122 by RIZIV\/INAMI in Belgium"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">ROCKAWAY, N.J., Sept.  29, 2025  (GLOBE NEWSWIRE) &#8212; electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that gammaCore\u2122 Sapphire (nVNS) has been included in a long-term reimbursement policy launched by the National Institute for Health and Disability Insurance (RIZIV \/ INAMI) in Belgium.<\/p>\n<p>Effective October 1, 2025, the policy provides coverage for gammaCore Sapphire to treat patients with cluster headaches. This coverage is based on strong clinical evidence supporting the therapy\u2019s efficacy and cost-effectiveness and ensures broader access for Belgian patients.<\/p>\n<p>\u201cThe reimbursement of gammaCore by RIZIV \/ INAMI is a remarkable step forward for patients suffering from cluster headaches in Belgium,\u201d said Prof. Paemeleire, leading the Headache Clinic of the Neurology Department at Ghent University Hospital. \u201cThis decision reflects the growing recognition of the clinical and economic benefits of non-invasive vagus nerve stimulation. As a healthcare provider, I am pleased that this reimbursement will now allow more patients to access a therapy that can significantly improve their daily lives while contributing to a more sustainable healthcare system.\u201d<\/p>\n<p>This achievement was made possible through the leadership and commitment of Silvert Medical, electroCore\u2019s distribution partner in Belgium. Silvert Medical leveraged their local expertise and strong provider relationships, playing a key role in securing reimbursement. Silvert Medical remains a vital partner in supporting the rollout of gammaCore in Belgium and is committed to extending access to gammaCore in neighboring countries.<\/p>\n<p>\u201cSecuring long-term reimbursement in Belgium, in the center of Europe, is a major milestone in expanding access to our non-invasive therapies,\u201d said Tanja Martin, Senior Director of Strategic Product Lifecycle at electroCore. \u201cWe\u2019re proud to partner with Silvert Medical to bring gammaCore to patients in Belgium.\u201d<\/p>\n<p>Learn more about RIZIV \/ INAMI\u2019s reimbursement policy for gammaCore Sapphire <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZG3QVBR9mygPE1AUfTS-G1pVhTE4TiruKuwTzHTTZrno69NSe24sMGNK7mkXvnXLc6lYs6XQ6kMFrh4BW7CT9C1BlN_N5OqQLUwkUWnsMM13SNN3ytppl_HPxcrv76RhQSUeDx3BlTbWVPsIVtl0I3j6StJAZhfP5o3ruUMxz7W2sLkJ0d_bPZ0hgSMYxBVCNYjGfL4xE0MZCeJEeBRgsVzblio__Es7j_tzHATqNbJRrPb_oLtzZUclzWv3yUhvrq1vqgliXxXseBtc3_o7t_xeZiVru39jC9qk0oags5qgG5hrkVaIWfqJ-ZsK8RW4\" rel=\"nofollow\" target=\"_blank\">here<\/a>.<\/p>\n<p>\n        <strong>About electroCore, Inc.<\/strong>\n      <\/p>\n<p>electroCore, Inc. is a commercial stage bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company\u2019s two leading prescription products, gammaCore non-invasive vagus nerve stimulation (nVNS) and Quell neurostimulator, treat chronic pain syndromes through non-invasive neuromodulation technology. Additionally, the company commercializes its handheld, and personal use Truvaga and TAC-STIM nVNS products utilizing bioelectronic technologies to promote general wellness and human performance.<br \/>For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=D03kUCRGgMUmjahZ3vObmKWTlW2sl5_Uae6uGHvaY068GB1nsnKUrTk_Kmjo52uLYMk5H56F5tllqBw02r77u01WZj0-iWlVOc7P2_S2x4Q=\" rel=\"nofollow\" target=\"_blank\">www.electrocore.com<\/a>.<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong><br \/>\n        <br \/>This press release and other written and oral statements made by representatives of electroCore may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements about reimbursement for gammaCore in Belgium and potential European expansion, the Company\u2019s future business strategies, growth opportunities, prospects, product development, and market expansion, and other statements that are not historical in nature, particularly those that utilize terminology such as \u201canticipates,\u201d \u201cwill,\u201d \u201cexpects,\u201d \u201cbelieves,\u201d \u201cintends,\u201d and other words of similar meaning, derivations of such words and the use of future dates. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the ability to use strategic partnerships to provide more accessibility to those looking to purchase our consumer devices, the inherent uncertainties associated with developing new products or technologies, the ability to commercialize its products, electroCore\u2019s results of operations and financial performance, inflation and currency fluctuations, and any expectations electroCore may have with respect thereto, competition in the industry in which electroCore operates and overall economic and market conditions. Any forward-looking statements are made as of the date of this press release, and electroCore assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law. Investors should consult all of the information set forth herein and should also refer to the risk factor disclosure set forth in the reports and other documents electroCore files with the SEC available at www.sec.gov.<\/p>\n<p>\n        <strong>Contact:<\/strong>\n      <\/p>\n<p>ECOR Investor Relations<br \/>(973) 302-9253<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0PClGCpGXk-vq8mTik0mtOWkidswIwLzXNhy49BReWL6daxX5a_emlC2hicDhoMOZTbh4u26JYnniF8EguK9PaExm-MR9h6KoYli2RVvOxqI5AlcvOHoCMLV7vdnFPzb\" rel=\"nofollow\" target=\"_blank\">investors@electrocore.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzNjE1MSM3MTY3ODkwIzIwOTg3NDQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZTc2NGU5Y2MtNTBjOS00YmQyLTk0OWYtODk0ZmVkNGQ3ZTU2LTExMTAzMTUtMjAyNS0wOS0yOS1lbg==\/tiny\/electroCore-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ROCKAWAY, N.J., Sept. 29, 2025 (GLOBE NEWSWIRE) &#8212; electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that gammaCore\u2122 Sapphire (nVNS) has been included in a long-term reimbursement policy launched by the National Institute for Health and Disability Insurance (RIZIV \/ INAMI) in Belgium. Effective October 1, 2025, the policy provides coverage for gammaCore Sapphire to treat patients with cluster headaches. This coverage is based on strong clinical evidence supporting the therapy\u2019s efficacy and cost-effectiveness and ensures broader access for Belgian patients. \u201cThe reimbursement of gammaCore by RIZIV \/ INAMI is a remarkable step forward for patients suffering from cluster headaches in Belgium,\u201d said Prof. Paemeleire, leading the Headache Clinic of the Neurology Department at Ghent &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;electroCore Announces Reimbursement Approval for gammaCore\u2122 by RIZIV\/INAMI in Belgium&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-890141","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>electroCore Announces Reimbursement Approval for gammaCore\u2122 by RIZIV\/INAMI in Belgium - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"electroCore Announces Reimbursement Approval for gammaCore\u2122 by RIZIV\/INAMI in Belgium - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ROCKAWAY, N.J., Sept. 29, 2025 (GLOBE NEWSWIRE) &#8212; electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that gammaCore\u2122 Sapphire (nVNS) has been included in a long-term reimbursement policy launched by the National Institute for Health and Disability Insurance (RIZIV \/ INAMI) in Belgium. Effective October 1, 2025, the policy provides coverage for gammaCore Sapphire to treat patients with cluster headaches. This coverage is based on strong clinical evidence supporting the therapy\u2019s efficacy and cost-effectiveness and ensures broader access for Belgian patients. \u201cThe reimbursement of gammaCore by RIZIV \/ INAMI is a remarkable step forward for patients suffering from cluster headaches in Belgium,\u201d said Prof. Paemeleire, leading the Headache Clinic of the Neurology Department at Ghent &hellip; Continue reading &quot;electroCore Announces Reimbursement Approval for gammaCore\u2122 by RIZIV\/INAMI in Belgium&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-29T13:30:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzNjE1MSM3MTY3ODkwIzIwOTg3NDQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"electroCore Announces Reimbursement Approval for gammaCore\u2122 by RIZIV\\\/INAMI in Belgium\",\"datePublished\":\"2025-09-29T13:30:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\\\/\"},\"wordCount\":663,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUzNjE1MSM3MTY3ODkwIzIwOTg3NDQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\\\/\",\"name\":\"electroCore Announces Reimbursement Approval for gammaCore\u2122 by RIZIV\\\/INAMI in Belgium - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUzNjE1MSM3MTY3ODkwIzIwOTg3NDQ=\",\"datePublished\":\"2025-09-29T13:30:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUzNjE1MSM3MTY3ODkwIzIwOTg3NDQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUzNjE1MSM3MTY3ODkwIzIwOTg3NDQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"electroCore Announces Reimbursement Approval for gammaCore\u2122 by RIZIV\\\/INAMI in Belgium\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"electroCore Announces Reimbursement Approval for gammaCore\u2122 by RIZIV\/INAMI in Belgium - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\/","og_locale":"en_US","og_type":"article","og_title":"electroCore Announces Reimbursement Approval for gammaCore\u2122 by RIZIV\/INAMI in Belgium - Market Newsdesk","og_description":"ROCKAWAY, N.J., Sept. 29, 2025 (GLOBE NEWSWIRE) &#8212; electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that gammaCore\u2122 Sapphire (nVNS) has been included in a long-term reimbursement policy launched by the National Institute for Health and Disability Insurance (RIZIV \/ INAMI) in Belgium. Effective October 1, 2025, the policy provides coverage for gammaCore Sapphire to treat patients with cluster headaches. This coverage is based on strong clinical evidence supporting the therapy\u2019s efficacy and cost-effectiveness and ensures broader access for Belgian patients. \u201cThe reimbursement of gammaCore by RIZIV \/ INAMI is a remarkable step forward for patients suffering from cluster headaches in Belgium,\u201d said Prof. Paemeleire, leading the Headache Clinic of the Neurology Department at Ghent &hellip; Continue reading \"electroCore Announces Reimbursement Approval for gammaCore\u2122 by RIZIV\/INAMI in Belgium\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\/","og_site_name":"Market Newsdesk","article_published_time":"2025-09-29T13:30:25+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzNjE1MSM3MTY3ODkwIzIwOTg3NDQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"electroCore Announces Reimbursement Approval for gammaCore\u2122 by RIZIV\/INAMI in Belgium","datePublished":"2025-09-29T13:30:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\/"},"wordCount":663,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzNjE1MSM3MTY3ODkwIzIwOTg3NDQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\/","name":"electroCore Announces Reimbursement Approval for gammaCore\u2122 by RIZIV\/INAMI in Belgium - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzNjE1MSM3MTY3ODkwIzIwOTg3NDQ=","datePublished":"2025-09-29T13:30:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzNjE1MSM3MTY3ODkwIzIwOTg3NDQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzNjE1MSM3MTY3ODkwIzIwOTg3NDQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/electrocore-announces-reimbursement-approval-for-gammacore-by-riziv-inami-in-belgium\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"electroCore Announces Reimbursement Approval for gammaCore\u2122 by RIZIV\/INAMI in Belgium"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/890141","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=890141"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/890141\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=890141"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=890141"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=890141"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}